{"id":"NCT03350906","sponsor":"Mayo Clinic","briefTitle":"Enhancing Adaptations to Exercise","officialTitle":"Enhancing Adaptations to Exercise","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-01-01","primaryCompletion":"2021-12-31","completion":"2021-12-31","firstPosted":"2017-11-22","resultsPosted":"2023-11-14","lastUpdate":"2023-11-14"},"enrollment":63,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Inflammation"],"interventions":[{"type":"DRUG","name":"n3-PUFA","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"PROCEDURE","name":"Biopsy","otherNames":[]},{"type":"DIAGNOSTIC_TEST","name":"Body Composition Scan","otherNames":["DEXA (dual-energy X-ray absorptiometry) scan."]}],"arms":[{"label":"n3-PUFA","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Researchers are trying to understand how chronic inflammation affects muscle function and responses to exercise.They are also trying to determine if suppressing chronic inflammation using omega-3 fatty acids (n3-PUFA) restores skeletal muscle function and exercise responsiveness in older adults.","primaryOutcome":{"measure":"Change in Maximum Workload Muscle Strength","timeFrame":"baseline, 6 months","effectByArm":[{"arm":"n3-PUFA (Docosahexaenoic Acid (DHA)/EPA)","deltaMin":7.5,"sd":14.1},{"arm":"Placebo","deltaMin":3.1,"sd":14.7}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":14},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["38547208","35389487"],"seeAlso":["https://www.mayo.edu/research/clinical-trials"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":30},"commonTop":[]}}